Literature DB >> 9825229

Plasma and tissue resveratrol concentrations and pharmacological activity.

A Bertelli1, A A Bertelli, A Gozzini, L Giovannini.   

Abstract

In this study a comparison was made between results obtained from resveratrol dosages which have been shown to be pharmacologically active, in vitro and in vivo, and the results of plasma and tissue concentrations obtained after a single administration or after prolonged administration of red wine with a known resveratrol content. The dosages used by different investigators in the tests are very different and, in general, rather high in relation to the concentrations which are found in wine or grapes. The results of our tests on platelet aggregation confirm that even with modest dosages of resveratrol, a pharmacological effect can be observed, and that these dosages can be compatible with the resveratrol concentrations obtained after oral administration. The data obtained from these tests on animals can lead to the conclusion that even an average drinker of wine can, particularly in the long term, absorb a sufficient quantity of resveratrol to explain the beneficial effect of red wine on health, which has been observed in epidemiological studies carried out in populations whose daily diet includes the drinking of wine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9825229

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  21 in total

1.  Phytoestrogens: food or drug?

Authors:  Lucia Bacciottini; Alberto Falchetti; Barbara Pampaloni; Elisa Bartolini; Anna Maria Carossino; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

2.  Effects of resveratrol in inflammatory arthritis.

Authors:  N Elmali; O Baysal; A Harma; I Esenkaya; B Mizrak
Journal:  Inflammation       Date:  2007-04       Impact factor: 4.092

3.  Inhibition of cardiac voltage-gated sodium channels by grape polyphenols.

Authors:  C H R Wallace; I Baczkó; L Jones; M Fercho; P E Light
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

4.  Suppression of human monocyte tissue factor induction by red wine phenolics and synthetic derivatives of resveratrol.

Authors:  Gurjeet Kaur; Marinella Roberti; Francis Raul; Usha R Pendurthi
Journal:  Thromb Res       Date:  2006-02-28       Impact factor: 3.944

5.  Resveratrol-induced gene expression profiles in human prostate cancer cells.

Authors:  Sunita B Jones; Samuel E DePrimo; Michael L Whitfield; James D Brooks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-03       Impact factor: 4.254

6.  Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons.

Authors:  S Bastianetto; W H Zheng; R Quirion
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

7.  Resveratrol inhibits cell growth by inducing cell cycle arrest in activated hepatic stellate cells.

Authors:  Izabel C Souza; Leo Anderson M Martins; Barbara P Coelho; Ivana Grivicich; Regina M Guaragna; Carmem Gottfried; Radovan Borojevic; Fátima Costa Rodrigues Guma
Journal:  Mol Cell Biochem       Date:  2008-05-04       Impact factor: 3.396

8.  Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes.

Authors:  Feng-Cheng Liu; Li-Feng Hung; Wan-Lin Wu; Deh-Ming Chang; Chuan-Yueh Huang; Jenn-Haung Lai; Ling-Jun Ho
Journal:  Arthritis Res Ther       Date:  2010-09-08       Impact factor: 5.156

Review 9.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Effect of Resveratrol and Nicotine on PON1 Gene Expression: In Vitro Study.

Authors:  Nidhi Gupta; Ramesh Kandimalla; Kumari Priyanka; Gagandip Singh; Kiran Dip Gill; Surjit Singh
Journal:  Indian J Clin Biochem       Date:  2013-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.